World Psychiatric Association
International Congress
Programme of November 10-13, 2004 Florence, Italy
In collaboration with the Italian Psychiatric Association, the Italian Society of Biological Psychiatry and the Italian Society of Neuropsychopharmacology.
www.wpa2004florence.org
CONTENTS
UPDATE LECTURES
UL1. The context of treatment in psychiatry . 1
UL2. Empathy, meaning, and the therapeutic alliance in psychiatric practice . 1
UL3. The comprehensive management of schizophrenia . 1
UL4. Early psychosis : detection and interventions . 1
UL5. The comprehensive management of recurrent major depression . 2
UL6. Comprehensive long-term management of bipolar disorder . 2
UL7. Understanding and managing the consequences of violence and trauma . 2
UL8. Integrating pharmacotherapy and psychotherapy in the management of anxiety disorders . 3
UL9. Evidence based management of dementia . 3
UL10. The multimodal treatment of eating disorders . 3
UL11. The principles and practice of cognitive-behavioural psychotherapy . 4
UL12. Psychodynamic psychotherapies : evidence-based and clinical wisdom . 4
UL13. Integration of services in community mental health care . 4
UL14. The challenge of primary prevention in psychiatry . 5
SPECIAL LECTURES
SL1. Current treatment in psychoses : did it change the outcome ? . 5
SL2. Comprehensive diagnosis as a basis for integrated treatment and health promotion . 5
INTERACTIVE SYMPOSIA
181. The future of psychotherapies 6
1S2. The contribution of neuroirnaging research to clinical psychiatry . 7
IS3. The future of pharmacotherapy for mood and anxiety disorders . 8
IS4. Cultural issues in mental health care . 9
IS5 The current management of personality disorders . 10
IS6. The management of somatoform disorders and medically unexplained physical symptoms . 11
IS7. New strategies in the management of sexual disorders . 12
IS8. Partnerships in mental health care . 13
IS9. Current approaches to autism . 14
ISIO. Current approaches to sleep disorders . 15
IS11. The present and future of consultation-liaison psychiatry . 17
IS12. Combining medications in psychiatry : advantages and risks . 18
IS13. The evaluation of psychiatric treatments . 19
IS14. Advances in the diagnosis and treatment of bipolar disorder . 20
IS15. Recent advances in pharmacogenomics . 21
IS16. The present and future of rehabilitation in psychiatry . 22
IS17. Management of alcohol-related problems . 23
IS18. Non-pharmacological somatic therapies in psychiatry . 24
IS19. Ethical and legal aspects of treatments in psychiatry . 26
IS20. Diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD) . 27
IS21. The current management of obsessive-compulsive disorder . 28
IS22. Understanding and managing « comorbidity » in psychiatry . 29
IS23. Economic aspects of mental health care . 30
IS24. Assessment and management of social anxiety disorder . 31
IS25. The future of pharmacotherapy for schizophrenia . 32
IS26. Family interventions for mental disorders . 33
IS27. Molecular genetics and genomics of psychiatric disorders : identification of novel drug targets . 34
IS28. Prevention and management of substance abuse . 35
IS29. Psychotropic drugs and cognitive functions . 37
IS30. « Difficult » children and adolescents : underdiagnosis and overdiagnosis of mental disorder and relevant treatment issues . 38
IS31. Gender-related issues in psychiatric treatments 39
IS32. New strategies for the care of the mentally retarded . 40
IS33. Epidemiology and prevention of suicide . 41
IS34. Management of mental disorders in old age . 42
IS35. The current management of panic disorder and generalized anxiety disorder . 43
IS36. The management of non-schizophrenic psychotic disorders . 44
SPECIAL WHO/WPA SYMPOSIA
SPS1. From advances in neuroscience of substance use disorders to new treatment approaches . 45
SPS2. Nosological validity and diagnostic validity . 46 SECTION SYMPOSIA SS1. Current questions in the treatment of bipolar disorders . 48
SS2. Diagnosing personality disorders : does it matter for treatment ? . 50
SS3. The educational challenge of improving the quality of psychiatric treatment . 51
S84. Spirituality, treatment and health . 52
SS5. Art and therapeutic communication . 53
SS6. Developing and implementing training in old age psychiatry . 54
SS7. Hormones as treatments of affective disorders . 55 SS8. The effect of disability pension policy on outcome from mental illness . 56
SS9. Management of first episode schizophrenia . 57
SSIO. Stress, depression and cardiac events . 59
SS11. Sexual health educational programme : an update . 59
SS12. Conceptual and ethical issues in early diagnosis and treatment . 59
SS13. Family functioning and family interventions in axis I and axis III disorders . 61
SS14. Predictors of response to therapies for eating disorders . 62
SS15. Psychiatric issues in psycho-oncology : SPECIAL WHO/WPA SYMPOSIA
SPS1. From advances in neuroscience of substance use disorders to new treatment approaches 45
SPS2. Nosological validity and diagnostic validity 46
SECTION SYMPOSIA SS1. Current questions in the treatment of bipolar disorders 48 SS2. Diagnosing personality disorders : does it matter for treatment ? so SS3. The educational challenge of improving
the quality of psychiatric treatment 51
S84. Spirituality, treatment and health 52
SS5. Art and therapeutic communication 53
SS6. Developing and implementing training SS38 in old age psychiatry 54 SS7. Hormones as treatments of affective SS39
disorders 55 SS40 SS8. The effect of disability pension policy on outcome from mental illness 56 SS41
SS9. Management of first episode schizophrenia 57
SSIO. Stress, depression and cardiac events 59
SS11. Sexual health educational programme : SS42 an update 59 SS12. Conceptual and ethical issues in early
diagnosis and treatment 59 SS43 SS13. Family functioning and family interventions in axis 1 and axis 111 disorders 61 SS14. Predictors of response to therapies for eating disorders 62 SS15. Psychiatric issues in psycho-oncology : a challenge for the new millennium . 64
SS16. Treatment of eating disorders in psychoanalytically informed psychiatry . 65
SS17. Biological correlates of disturbed sleep . 66
SS18. Treatment research on eating disorders . 67
SS19. Psychopathology and treatment . 68
SS20. Childhood sexual abuse, paraphilias and sex offence : are they related ? . 69
SS21. Labour, law and disability . 70
SS22. European psychiatry from 1800 to 2004 : institutions, concepts and policies . 71
SS23. Psychiatry, law and ethics . 72
SS24. Interventions in disasters . 73
SS25. The role of the psychiatrist in the HIV/AIDS epidemic . 74
SS26. Psychophysiological characterization of mental disorders : therapeutic implications . 74
SS27. Access to care impediments : African, American and European experiences . 76
SS28. Military psychiatry . 77
SS29. Quality improvement : practice guidelines and suicide prevention . 78
SS30. New perspectives on neuroirnaging in schizophrenia . 79
SS31. Well-being and quality of life in the 21st century . 80
SS32. Ecological changes and mental distress : therapeutic perspectives . 81
SS33. Topics of prevention : evidence and research . 82
SS34. Updating suicidology . 83
SS35. Psychoimmunology : evidence and perspectives . 84
SS36. Evolutionary psychopathology : toward empirical and epigenetic explanations . 85
SS37. Intervention strategies for mental retardation : an integrative approach .86
SS38. The use of psychoanalysis in today’s urban mental health settings . 87
SS39. Violence against women across cultures . 88
SS40. Genetics and psychopathology of suicidal behaviours . 89 SS41. The MIND clinical imaging consortium : a multimodality collaborative study of schizophrenia . 90
SS42. Rehabilitation of torture victims and the problems of these victims from the psychiatrist’s viewpoint . 92
SS43. Depression associated with medical conditions in primary care and other settings .93
SS44. Transcultural psychiatry in Europe : something is going on . 94
SS45. Positive and negative impact of new technologies in psychiatric sciences . 95
SS46. The hidden burden of mental retardation . 96
SS47. Psychosis : meaning, mechanism and interpersonal consequences . 97
SS48. The relevance of neuropsychophysiological research to psychiatric treatment . 97
SS49. Attention-deficit /hyperactivity disorder in primary care . 98
SS50. Violence : a man made disaster . 99
SS51. Substance abuse and the family . 100
SS52. Settings and techniques of intervention in emergency psychiatry : a comparaison of different models . 101
SS53. Common mental disorders in private practice . 102
ZONAL SYMPOSIA
ZS1 Interdisciplinary approaches to treatment of mental disorders : the experience of Eastern Europe . 104
ZS2. Partnership in mental health care in Afric . 105
ZS3. Mental health and psychiatry in Latin America . 106
ZS4. Developing the identity of the contemporary European psychiatrist . 106
ZS5. Administration of health services and educational programs in Latin America . 107
ZS6. Perspectives on psychotherapy from the US . 108
ZS7. Mental health services in North Africa . 109
ZS8. Psychiatry in Central European countries within the process of affiliation to the European Union . 110
ZS9. Mental health and primary care services working together : the Canadian experience . 112
ZS10. Modern and traditional treatments in the context of a developing country . 113
ZS11. Community psychiatry in the Mediterranean region and the role of psychiatric associations . 113
WORKSHOPS
W01. Disasters, terrorism and trauma . 115
W02. Training in psychiatric treatment in different European countries . 116
W03. Diagnosis and treatment of catatonia . 117
W04. HIV/AIDS and psychiatric disorders . 118
W05. Methodological challenges in non-industry-sponsored multicenter clinical trials . 118
W06. Diagnosing and treating social phobia . 120
W07. Comparing mental health and risk factors across European Union countries . 121
W08. International perspectives on coercive treatment in psychiatry . 123
W09. Recent advances in brain imaging of drug abuse . 124
W010. Successful implementation of evidence-based family treatment for mental disorders . 125
W011. Suicide prevention in major psychoses : risk factors and role of long-term treatment . 126
W012. The GABA neuron and schizophrenia morbidity : treatment implications . 127
W013. International perspectives on mental health services for youth in prison . 129
W014. European guidelines on privacy and confidentiality in healthcare . 130
W015. Court-ordered psychiatric treatment in New York City . 130
W016. The prevalence of mental disorders in Europe and Italy : results of the European Study of Epidemiology of Mental Disorders (ESEMeD) . 131
W017. Psychiatric therapies in movies . 132
W018. The atypical psychoses : from psychopathology to neurobiology . 133
W019. Epidemiology, clinical picture and treatment of childhood depression . 134
W020. How to organize a scientific congress . 134
W021. Treatments in psychiatry : young psychiatrists’ knowledge and attitudes in various countries . 136
W022. Strategies for psychotropic drugs of the future . 137
W023. Current approaches to severe personality disorders . 139
W024. Targeted combination of drugs or polypharmacy ? Evidence for and against combined drug treatment . 140
W025. Perspectives in psychiatric training : implications for treatment . 141
W026. Psychotherapy for childhood depression : a cross-national European study . 142
W027. Treatment of limits, limits of treatment . 143
W028. Involving patients and families in integrated psychiatric treatments . 144
W029. Mental health issues in HIV/AIDS . 145
W030. Implementation of psychoeducational interventions for schizophrenia in routine clinical settings . 145
W031. The evolution of community psychiatry in Italy . 147
W032. Predicting response to antipsychotics and antidepressants by functional imaging . 148
W033. Treatment of personality disorders : new perspectives . 149
W034. Biological correlates and treatment of pathological gambling . 150
W035. Psychiatry in the countries of Eastern Europe and the Balkans : similarities and differences . 151
W036. Autism in schizophrenia, today . 152
W037. Clinical research on impulsivity : new developments and directions for possible treatments . 153
W038. Teaching and learning core competencies of basic consultation/liaison psychiatry . 154
W039. The current role of psychotherapy in graduate psychiatric training . 155
W040. Innovative approaches to outcome assessment of psychosocial interventions in severe mental disorders . 157
W041. How to improve adherence to psychiatric treatments . 157
W042. Obsessive-compulsive disorder : from serotonin to other monoamines and back again . 158
W043. Guideline development and implementation in psychiatry . 159
WO44. The current management of Alzheimer’s disease . 160
W045. Coming-out and health care for young homosexuals . 161
W046. Cognitive dysfunction in schizophrenia : from evaluation to treatment . 162
W047. Early psychosis : new strategies for prevention and rehabilitation . 163
W048. Therapeutic factors in the different psychotherapeutic methods . 164
W049. Update on research in psychiatric treatment issues for lesbian, gay, bisexual and transgender patients . 165
W050. Psychiatry in forensic settings . 165
W051. Pharmacological and non-pharmacological treatment issues concerning schizophrenia in Korea . 166
W052. Inpatient treatment of personality disorders . 167
W053. An integrated research-based approach to treating first episode psychosis . 168
NEW RESEARCH SESSIONS
NRS1. Psychotic disorders (1) . 169
NRS2. Primary care and liaison psychiatry . 171
NRS3. Community psychiatry (1) . 173
NRS4. Biological research . 174
NRS5. Mood disorders (1) . 176
NRS6. Improving psychiatric practice . 178
NRS7. Personality disorders and aggressive behaviour . 180
NRS8. Psychotic disorders (11) . 182
NRS9. Mood disorders (11) . 183
NRS10. Psychotic disorders (111) . 185
NRS11. Child and adolescent psychiatry (1) . 186
NRS12. Psychotic disorders (IV) . 188
NR813. Child and adolescent psychiatry (11) . 190
NRS14. Cultural and preventive psychiatry . 191
NRS15. New and traditional approaches in mental health care in developing countries . 193
POSTER SESSIONS
P0l. Psychotic disorders 194
P02. Mood, anxiety and eating disorders ; child psychiatry ; substance abuse . 245
P03. Old age, consultation-liaison and forensic psychiatry ; psychiatric services ; psychotherapies . 309
SPONSORED SYMPOSIA
SAS1. Free your patients from depression : treating the spectrum of symptoms . 350
SAS2. Escitalopram : innovation through evolution . 350
SAS3. Controversies and consensus in the management of bipolar depression . 352
SAS4. Novel ways to understand depression . 353
SAS5. The psychiatric patient : new treatment perspectives across the lifespan . 354
SAS6. Beyond depression and anxiety : understanding treatment myths and facts . 356
SAS7. Integrating science and medicine : strategies for the management of bipolar disorder . 357
SAS8. Clinical strategies in managing schizophrenia and bipolar disorder . 358
SAS9. The many phases of bipolar disorders : epidemiology and management . 359
SAS10. Attention-deficit/hyperactivity disorder (ADHD), a life-long impairing disorder : an international perspective . 360
SAS11. Role of antipsychotics in the treatment of bipolar disorder : from acute symptom control to long-term management . 361
SAS12. The boundaries of anxiety . 362
SAS13. Maintaining global patient health in the treatment of psychiatric disorders . 363
SAS14. Raising the bar in the treatment of patients with mood and anxiety disorders . 364
INDEX OF AUTHORS 367